Adrenal disease

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study

Eur J EndocrinolPublished Retrospective cohort study

Main finding · LVHResult — go to the resultOdds ratio 2.0 95% CI 1.23–3.25

Authors' conclusion

Patients with PA who smoke have a higher prevalence of LVH and MACS and larger adrenal nodule/s than non-smokers. Smoking has no significant effect on the probability of hypertension response after adrenalectomy in patients with PA; however, a tendency to a lower probability of hypertension cure is observed in smokers compared to non-smokers.

Study context

Population
Patients with PA evaluated in 36 Spanish tertiary hospitals with available information on smoking habits
Participants
881 patients
Exposure
Smokers vs non-smokers
  • Smokersn = 180
  • Non-smokersn = 701reference
Outcome
Left ventricular hypertrophy (LVH)
Follow-up
At diagnosis
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Odds ratio

2.0

95% CI 1.23–3.25

Smokersvs Non-smokers
OR 2.0 (95% CI 1.23–3.25)

Observational data: associations, not effects.

Further findings

Severe LVH

P = 0.164

Hypertension cure · tended to be more frequent with non-smokers

P = 0.076

Tumour size of adrenal nodule/s

P = 0.002

OutcomeEstimate
MACSOR 2.1 (95% CI 1.14–4.06)
MACSAdjusted for size of adrenal nodule/saOR 1.6 (95% CI 0.76–3.37)

Biochemical and hypertension cure after adrenalectomy

Rate of biochemical and hypertension cure similar in both groups

Original publication

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study. Eur J Endocrinol. Published 18 November 2024. doi:10.1093/ejendo/lvae143

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.